BioNTech SE(NASDAQ:BNTX) 
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa...
Website: http://www.biontech.de
Founded: 2008
Full Time Employees: 1,800
CEO / Founder: Ugur Sahin
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 88.32
H 89.61
L 86.25
C 88.05
V 1,035,719
10EMA 88.05
20EMA 88.05
60EMA 88.05
120EMA 88.05
250EMA 88.05